Lumen Results Presentation Deck
YoY Adj. EBITDA Change: Previous and Current Outlook
Updating our Outlook Based on Adjusted Timing of the 20-state ILEC Business Divestiture
$8.4B
FY21 Adj. EBITDA
15
Issued: May 4, 2022
-$490M
CAF II
Support
-$850M
Original Deal
Impacts Assumed (1)
-$400M to -$600M
Other (2)
$6.5B to
$6.7B
FY22 Adj. EBITDA
(Prev. Outlook)
- $400M
Current Deal
Impacts Assumed
(3)
(1) The previous outlook assumed that the pending sales of Lumen's LATAM business and 20-state ILEC business would be completed at mid-year 2022,
resulting in 2022 financial contributions of two quarters for each business.
$6.9B to
$7.1B
FY22 Adj. EBITDA
(Current Outlook)
(2) Includes impact of revenue declines, investments for growth and separation-related activities resulting in dis-synergies and lower transformation savings.
(3) The current outlook assumes the pending sales of Lumen's LATAM business and 20-state ILEC business would be completed in the third quarter of 2022
and the fourth quarter of 2022, respectively, resulting in 2022 financial contributions of two quarters and three quarters, respectively for each business.
LUMENⓇView entire presentation